CD4 and neoplasm: Moreover, NLRC4/NAIP5 also participated in the antigen recognition of flagellin-expressing tumor cells to facilitate antigen presentation to T cells, thereby activating CD4+ and CD8+ T cells and exerting antitumor effects (Garaude et al., 2012).